The contraceptives market is anticipated to undergo steady growth sue to increasing public awareness about reproductive health, prime driving factors of the global contraceptives market are technical advancement, preference for avoiding unintentional pregnancy and availability of highly effective female contraceptives. Increasing focus of government initiatives towards enhancing the status of women’s health and escalating prevalence of sexually transmitted infections are further driving the global contraceptives market. Growing preference for novel permanent and long-term contraceptives is being increasingly observed in low-income countries.
This report segments the global contraceptives market for the commercially available products and regional markets. Contraceptives drugs and devices are the product types studied in this report. Oral contraceptive pills, topical contraceptives and contraceptive injectables are the drug types considered in this study. On the other hand, the device types scrutinized are male condoms, female condoms, diaphragms, contraceptive sponges, vaginal rings, subdermnal implants and intrauterine devices. This report demonstrates the market size and forecast for each segment type for the period 2014-2023, along with respective CAGRs for the forecast duration 2016-2023.
Geographically, the global contraceptives market is studied for the following regional markets:
The market size and forecast for the period 2014-2023 along with the CAGRs for the period 2016-2023 for the mentioned segments are also presented in this study. Cumulative presentation, market size and forecast of drugs and devices segments for individual country level markets are also provided in this report.
Qualitative information sets such as market dynamics (drivers, challenges, future prospects) and market inclination insights are provided in this market assessment report. Tools such as competition assessment and attractive investment proposition are also included in this study for studying the global market competition. The report concludes with company profiles section that highlights key information about the major market players operating in the global contraceptives market.
Condoms are undoubtedly the most widely used contraceptive devices in use. Acknowledgement of condoms both as an effective measure in preventing pregnancies and protection against sexually transmitted infections and diseases is the greatest driver of condoms market. Product variation in terms of structure and material such as polymers and nanomaterials to the latest uniform size products further add to the awareness about condoms in the global market. Despite the robust advantages, there are certain factors that challenge the condoms market. Social stigma associated with use of condoms and lack of awareness and education significantly restrain the demand for condoms in less developed regions of the world. However, government initiatives towards increasing awareness about the benefits of condoms in the male population and the latest introduction of female condoms will significantly lessen the impact of market restraints.
Oral contraceptive pills, injectable contraceptives and topical contraceptives are the drug types studied in the contraceptives market.
Oral contraceptives are the most common type of reversible contraceptive method used worldwide. These contraceptives include progestin and estrogen hormones for interfering with ovulation and fertilization. Emergency contraceptives are observed to be in high demand both in developed and developing markets. It is also estimated that over 90% women have uses contraceptive pills at least once in lifetime. However, their inability in preventing sexually transmitted infections and potential side effects deviate user preference towards the safer and cheaper condoms. Novel products as subdermal implants and vaginal rings are observing high demand in the developed markets due to their high effectiveness in preventing pregnancies for longer durations.
North America, particularly the United States is the largest market for contraceptive drugs and devices on the global platform. Wide availability of full range of products, cheap costs, and high awareness are the prime factors that drive the contraceptives market in North America. Demand for novel products such as subdermal implants, vaginal rings, sponges and patches is significantly high in North America and Europe due to high awareness and higher disposable incomes. On the other hand, Asia-Pacific and Latin America are the most opportunistic markets for contraceptives. Increasing education initiatives by governments towards sexual wellbeing and prevention of sexually transmitted diseases, and rising preference for population control and family planning significantly contribute to the growth of contraceptives market in these regions.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Contraceptives market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Drugs
| |
Devices
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
